Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Basic & Clinical Pharmacology & Toxicology|April 8, 2014
Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoringFederico Pea, Lucia Dose, Piergiorgio Cojutti, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 21, 2019
Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM-guided dosing adaptation helpful?Elda Righi, Alessia Carnelutti, Umberto Baccarani, et al.The Annals of Pharmacotherapy|July 14, 2011
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patientFederico Pea, Piergiorgio Cojutti, Rodolfo Sbrojavacca, et al.International Journal of Antimicrobial Agents|December 26, 2016
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?Federico Pea, Paola Della Siega, Piergiorgio Cojutti, et al.Antimicrobial Agents and Chemotherapy|December 16, 2015
Does Critical Illness Change Levofloxacin Pharmacokinetics?Jason A Roberts, Menino Osbert Cotta, Piergiorgio Cojutti, et al.Basic & Clinical Pharmacology & Toxicology|November 18, 2015
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP InducersPiergiorgio Cojutti, Anna Candoni, Fabio Forghieri, et al.Journal of Global Antimicrobial Resistance|May 21, 2026
Genome Sequence of a Methicillin-Resistant Staphylococcus epidermidis (MRSE) Resistant to Dalbavancin and Teicoplanin isolated in Italy, 2023Carlo Tascini, Michela Bulfoni, Simone Giuliano, et al.The Annals of Pharmacotherapy|September 25, 2008
Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patientFederico Pea, Umberto Baccarani, Marcello Tavio, et al.International Journal of Antimicrobial Agents|June 6, 2026
Emergence of Dalbavancin Non-Susceptible Methicillin-Resistant Staphylococcus epidermidis (MRSE) in a Patient Treated With Dalbavancin prolonged therapy: Case Report, Therapeutic Drug Monitoring and Genomic CharacterizationSimone Giuliano, PierGiorgio Cojutti, Michela Bulfoni, et al.Blood Transfusion = Trasfusione Del Sangue|December 29, 2022
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII StudyEzio Zanon, Samantha Pasca, Gianluca Sottilotta, et al.Pageof 4